Navigation Links
Array BioPharma To Hold Conference Call To Discuss Clinical Data Presentations In Melanoma And Colorectal Cancer On September 28, 2015
Date:9/25/2015

BOULDER, Colo., Sept. 25, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq:   ARRY) will hold a conference call to discuss preliminary results from two melanoma trials and a colorectal cancer trial on Monday, September 28, 2015.  Ron Squarer, Chief Executive Officer, and Victor Sandor, M.D., Chief Medical Officer, will lead the call.

The trials include a Phase 2 combination trial of binimetinib and encorafenib in BRAF-mutant melanoma patients (LOGIC2), a Phase 1b/2 combination trial of binimetinib and a CDK4/6 inhibitor in NRAS-mutant melanoma patients and a Phase 2 combination trial of encorafenib and an EGFR inhibitor with or without the addition of a PI3K inhibitor in patients with BRAF-mutant colorectal cancer.  Data from these trials will be presented at the European Society of Medical Oncology's (ESMO) annual European Cancer Conference (ECC) or were presented at the 2015 ESMO World Congress of Gastrointestinal Cancer. Conference Call InformationDate:Monday, September 28, 2015Time:9:00 a.m. eastern timeToll-Free:(844) 464-3927Toll:(765) 507-2598Pass Code:43837177Webcast, including Replay and Conference Call Slides:  http://edge.media-server.com/m/p/ky8z35w4/lan/enAbout Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162 / wholly-owned), encorafenib (LGX818 / wholly-owned) and selumetinib (AstraZeneca). For more information on Array, please go to www.arraybiopharma.com.

CONTACT:

Tricia HaugetoArray BioPharma Inc.(303) 386-1193thaugeto@arraybiopharma.com  Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO

 


'/>"/>
SOURCE Array BioPharma
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Array BioPharma Announces Clinical Data Presentations At The 2015 European Cancer Congress
2. Array BioPharma To Present At The Morgan Stanley Global Healthcare Conference
3. Array BioPharma To Present At The Wells Fargo Securities Healthcare Conference
4. Proxsys Rx Adds Turnkey 340B Plan Management to its Array of Services
5. Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015
6. Array BioPharma To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 On August 3, 2015
7. SCIENION and Anteo Partner to Develop Consumables for Better Functionality and Longer Shelf Life of Protein Microarrays
8. Array BioPharma To Present At The Cantor Fitzgerald 2015 Healthcare Conference
9. Global Array Instruments Market 2015-2019 - Advances in Personalized Medicines with Affymetrix, Agilent Technologies & Illumina Dominating
10. Accuratus Lab Services Expands Capabilities with Acquisition of CMC Operation of Array BioPharma
11. Array BioPharma Announces Clinical Data Presentations At The 2015 ASCO Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2017)... JERUSALEM , May 9, 2017  Oramed ... www.oramed.com ), a clinical-stage pharmaceutical company focused on ... today that the Canadian Intellectual Property Office has ... for Oral Administration of Exenatide". The patent covers ... analog. GLP-1 is an incretin hormone ...
(Date:5/6/2017)... , May 5, 2017   Provista , a proven ... than 200,000 customers, today announced Jim Cunniff as ... of executive and business experience to Provista, including most recently ... in California . He assumed his new ... is a great fit for Provista," says Jody Hatcher ...
(Date:5/4/2017)... Tenn. , May 4, 2017  A ... Infection Control, Ultraviolet-C light as a ... Tru-D SmartUVC,s ability to reduce bioburden on anesthesia ... bioburden reduction on high-touch, complex medical equipment surfaces ... surgical infections. "This study further validates ...
Breaking Medicine Technology:
(Date:5/19/2017)... (PRWEB) , ... May 19, 2017 , ... In a ... PlushBeds , a luxury online mattress company that specializes in natural and organic ... nation’s leading grassroots autism organization) for every unique share their recent viral Facebook ...
(Date:5/19/2017)... ... May 19, 2017 , ... DMG Productions is ... of Innovations with Ed Begley, Jr., airing fourth quarter 2017 on FOX Business. ... clean, organic dietary supplement made from naturally occurring ingredients. Innovations will enlighten viewers ...
(Date:5/19/2017)... ... 2017 , ... Springfield, Vermont-based law firm of Brady/Callahan has released a new ... Hire An Experienced Personal Injury Attorney, " the article offers insight for people who ... article says. if someone is injured due to another person's negligence, they ...
(Date:5/19/2017)... ... May 19, 2017 , ... The ... planning assistance to families and business owners in the region, is embarking on ... MS sufferers and their families. , Multiple sclerosis (MS) is a demyelinating disease ...
(Date:5/19/2017)... Reston, VA (PRWEB) , ... May 19, 2017 ... ... mobile application containerization, today announced a sponsorship and speaking session at the 7th ... Exchange is the longest-running hosted enterprise mobility and digital transformation conference whose expressed ...
Breaking Medicine News(10 mins):